These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5316477)

  • 1. The effect of 5-hydroxytryptophan on the efflux of noradrenaline from brain slices.
    Feer H; Wirz-Justice A
    Experientia; 1971 Aug; 27(8):885-6. PubMed ID: 5316477
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical correlates of behaviour--content of tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid, tyrosine, dopamine and norepinephrine in four brain parts of the pigeon during behavioural depression following an injection of tryptophan.
    Smith JE; Hingtgen JN; Lane JD; Aprison MH
    J Neurochem; 1976 Mar; 26(3):537-41. PubMed ID: 4584
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of GABA, picrotoxin and bicuculline on loss of noradrenaline and serotonin from rat brain mesodiencephalic region in vitro.
    Yessaian NH; Demirjian AH; Tozalakian BV
    J Neurochem; 1977 May; 28(5):1151-3. PubMed ID: 864465
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tryptophan on serotonin in nerve endings.
    McBride WJ; Hyde TP; Smith JD; Aprison MH; Lane JD
    J Neurochem; 1976 Jan; 26(1):175-8. PubMed ID: 1082926
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 5-hydroxytryptophan on serotonin in nerve endings.
    McBride WJ; Aprison MH; Hingtgen JN
    J Neurochem; 1974 Aug; 23(2):385-91. PubMed ID: 4547408
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 5-hydroxytryptophane on self-stimulation in rats.
    Bose S; Bailey PT; Thoa NB; Pradhan SN
    Psychopharmacologia; 1974 Apr; 36(3):255-62. PubMed ID: 4546509
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response relationships between systemically administered L-tryptophan or L-5-hydroxytryptophan and raphe unit activity in the rat.
    Trulson ME; Jacobs BL
    Neuropharmacology; 1976 Jun; 15(6):339-44. PubMed ID: 1084489
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin-containing neuronal perikarya and terminals: differential effects of P-chlorophenylalanine.
    Aghajanian GK; Kuhar MJ; Roth RH
    Brain Res; 1973 May; 54():85-101. PubMed ID: 4267802
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitory effect of 5-hydroxytryptophan on heart regulation during emergence from hibernation].
    Popova NK
    Dokl Akad Nauk SSSR; 1973 May; 210(2):496-8. PubMed ID: 4541420
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of analogs of phenylalanine and tryptophan on kinetics of DOPA decarboxylase in rat brain.
    De Ropp RS; Furst A
    Brain Res; 1966 Oct; 2(4):323-32. PubMed ID: 5298124
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of insulin on brain monoamine metabolism in rats.
    Berggren U; Engel J; Liljequist S
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):39-43. PubMed ID: 6412514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on 5-hydroxytryptophan decarboxylase activity in immature animals].
    Oshika H
    Nihon Yakurigaku Zasshi; 1966 Jul; 62(4):143-51. PubMed ID: 5297951
    [No Abstract]   [Full Text] [Related]  

  • 15. DL-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
    Fuxe K; Butcher LL; Engel J
    J Pharm Pharmacol; 1971 Jun; 23(6):420-4. PubMed ID: 4397180
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamines and the regulation of vigilance and sleep.
    Putkonen PT
    Med Biol; 1974 Jun; 52(3):193-9. PubMed ID: 4370645
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ; Watkins CJ
    Nature; 1977 Jan; 265(5589):79-80. PubMed ID: 834247
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro(5H-dibenzo(a,d)cycloheptene-5,1'-cycloalkanes).
    Carnmalm B; Jacupovic E; Johansson L; de Paulis T; Rämsby S; Stjernström NE; Renyi AL; Ross SB; Ogren SO
    J Med Chem; 1974 Jan; 17(1):65-72. PubMed ID: 4543291
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hypoxia on monoamine synthesis in brains of developing rats. III. Various O2 levels.
    Hedner T; Lundborg P; Engel J
    Biol Neonate; 1978; 34(1-2):55-60. PubMed ID: 29678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.